title: [Early diagnosis and treatment of Alzheimer's disease. Implementation in the doctor's office].
abstract: The efficacy of antidemential agents proven in comprehensive studies and by clinical experience, now justifies an active and positive approach by the general physician to the diagnosis and treatment of patients with dementia. The proposals on how to implement diagnostic and therapeutic measures in the doctor's office comply both with medical quality criteria and the requirements for appropriateness of treatment and considerations of economy stipulated by German law. They therefore provide the basis for a modern diagnostic work-up and treatment strategy, which will also meet economical demands.
authors.affiliation: Neurologische Universitätsklinik, Ulm. juekohler@aol.com
authors.forename: J
authors.initials: J
authors.lastname: Kohler
authors.forename: M W
authors.initials: MW
authors.lastname: Riepe
authors.forename: K
authors.initials: K
authors.lastname: Jendroska
authors.forename: H
authors.initials: H
authors.lastname: Pilartz
authors.forename: G
authors.initials: G
authors.lastname: Adler
authors.forename: F M
authors.initials: FM
authors.lastname: Berger
authors.forename: P
authors.initials: P
authors.lastname: Calabrese
authors.forename: L
authors.initials: L
authors.lastname: Frölich
authors.forename: H J
authors.initials: HJ
authors.lastname: Gertz
authors.forename: H
authors.initials: H
authors.lastname: Hampel
authors.forename: M
authors.initials: M
authors.lastname: Haupt
authors.forename: R
authors.initials: R
authors.lastname: Mielke
authors.forename: H J
authors.initials: HJ
authors.lastname: Paulus
authors.forename: D
authors.initials: D
authors.lastname: Zedlick
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy; D010054:Brief Psychiatric Rating Scale; D002219:Carbamates / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004088:Dihydroergotoxine / Q000627:therapeutic use; D000077265:Donepezil; D005194:Family Practice; D005260:Female; D005500:Follow-Up Studies; D005702:Galantamine / Q000627:therapeutic use; D020441:Ginkgo biloba; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D008297:Male; D008559:Memantine / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000627:therapeutic use; D009553:Nimodipine / Q000627:therapeutic use; D018697:Nootropic Agents / Q000627:therapeutic use; D048448:Phenylcarbamates; D010880:Piperidines / Q000627:therapeutic use; D010889:Piracetam / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012307:Risk Factors; D000068836:Rivastigmine; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use
chemical_list: D002219:Carbamates; D002800:Cholinesterase Inhibitors; D007189:Indans; D018696:Neuroprotective Agents; D018697:Nootropic Agents; D048448:Phenylcarbamates; D010880:Piperidines; D014665:Vasodilator Agents; D005702:Galantamine; D004088:Dihydroergotoxine; D009553:Nimodipine; D000077265:Donepezil; D000068836:Rivastigmine; D008559:Memantine; D010889:Piracetam